The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

Photo of the Day - HIV Drug Protests in Peru

January 22, 2015 3:14 pm | by Mike Auerbach, Editor In Chief | News | Comments

In Peru, BMS' atazanavir is available as a second-line HIV drug, but its high price is out of reach of many Peruvians with HIV/AIDS.                     


Senator Warren to File Bill Targeting Top Pharma Companies

January 22, 2015 2:24 pm | by STEVE LeBLANC, Associated Press | News | Comments

Warren's bill would require that whenever drug companies enter into a settlement with the government over alleged wrongdoing, they must pay a portion of their annual profits over five years to support research at the NIH and the FDA.   


One Dose, Then Surgery: A New Way to Test Brain Tumor Drugs

January 22, 2015 1:33 pm | by MARILYNN MARCHIONE, AP Chief Medical Writer | News | Comments

With special permission from the Food and Drug Administration and multiple drug companies, an Arizona hospital is testing medicines very early in development and never tried on brain tumors before.         


Scientifically Adept - Platform Agnostic: Particle Sciences Positions Itself as a Bioavailability Tool for Most Dosage Forms

January 22, 2015 11:50 am | by Mike Auerbach, Editor In Chief | Articles | Comments

Particle Sciences, a drug development services company located in Bethlehem, Pennsylvania, has based its business model on being platform/technology agnostic. Bring them your drug development, formulation or dosage form problem and they will apply the right set of tools and technology to advance your project.


Catalent Expands Integrated Softgel Operations Through Coating and Packaging Investment In Eberbach, Germany

January 22, 2015 10:44 am | News | Comments

Catalent Pharma Solutions will adding new coating and blister packaging equipment at its 360,000 sq ft, Eberbach, Germany softgel manufacturing facility, expanding the integrated softgel solutions available.       


Treatment Market for Irritable Bowel Syndrome Could Hit $1.5B by 2023, says GlobalData

January 22, 2015 9:11 am | News | Comments

The global therapeutics market for Irritable Bowel Syndrome (IBS) is set to rise in value from $589.6 million in 2013 to $1.5 billion by 2023, representing a high Compound Annual Growth Rate (CAGR) of almost 9.9%, says research and consulting firm GlobalData.


SP Acquires Stability Environments

January 22, 2015 8:38 am | News | Comments

SP Industries, a designer and manufacturer of laboratory equipment, biological drug manufacturing solutions, lab supplies and specialty glassware, announced today that it has acquired Stability Environments a provider of walk-in environmental rooms, glassware dryers, chambers and accessory products.


Possible Link Between Birth Control and Rare Brain Tumors

January 22, 2015 8:34 am | Videos | Comments

Researchers say that women who use birth control pills for five years or more may have an increased risk of brain tumors. Also, many adults do not get the weekly recommendations for physical activity.         


Coffee Study Shows It May Reduce Melanoma Risk

January 22, 2015 8:29 am | Videos | Comments

Having the dark brew may help prevent the most dangerous kind of skin cancer.                             


Fitch: SCOTUS Extends Patent Benefit for Teva; Generics Lose for Now

January 22, 2015 8:20 am | News | Comments

The Supreme Court (SCOTUS) decision that a federals appeals court wrongly overturned Teva Pharmaceutical's (Teva) Copaxone patent is a positive credit development for the drug maker, according to Fitch Ratings.       


New Government Standards Target Pathogens in Poultry Products

January 22, 2015 8:12 am | by MARY CLARE JALONICK, Associated Press | News | Comments

Standards proposed Wednesday by the Agriculture Department aim to reduce rates of salmonella and campylobacter, another pathogen that can cause symptoms similar to salmonella, in chicken parts, ground chicken and ground turkey. The standards would be voluntary but designed to pressure companies to take steps to reduce contamination.


Lab Tests Imply Formaldehyde Risk in Some E-cigarette Vapor

January 22, 2015 8:06 am | by MARILYNN MARCHIONE, AP Chief Medical Writer | News | Comments

Using certain electronic cigarettes at high temperature settings could potentially release more formaldehyde, a cancer-causing chemical, than smoking traditional cigarettes does, new lab tests suggest.        


Government Closer to Goal of 9.1M Enrolled Under Health Law

January 22, 2015 7:57 am | News | Comments

The Obama administration is moving closer to its goal of 9.1 million people signed up for private coverage under the president's health care law. The Health and Human Services Department says at least 400,000 people signed up last week.   


Disney Parks-Linked Measles Outbreak Grows to 70 Cases

January 22, 2015 7:54 am | by ALICIA CHANG, AP Science Writer | News | Comments

Seventy people have been infected in a measles outbreak that led California public health officials to urge those who haven't been vaccinated against the disease, including children too young to be immunized, should avoid Disney parks where the spread originated.


FDA Approves Novartis’ Cosentyx for Moderate-to-Severe Plaque Psoriasis

January 21, 2015 2:12 pm | News | Comments

Novartis announced that the FDA has approved Cosentyx (secukinumab) for the treatment of moderate-to-severe plaque psoriasis in adult patients who are candidates for systemic therapy or phototherapy.         



You may login with either your assigned username or your e-mail address.
The password field is case sensitive.